نتایج جستجو برای: FLT3-TKD835 mutation

تعداد نتایج: 293734  

Journal: :iranian journal of basic medical sciences 0
hossein ayatollahi cancer molecular pathology research center, ghaem hospital, faculty of medicine, mashhad university of medical sciences, mashhad, iran mohammad rafiee faculty of medicine, mashhad university of medical sciences, mashhad, iran mohammad-reza keramati cancer molecular pathology research center, ghaem hospital, faculty of medicine, mashhad university of medical sciences, mashhad, iran mahdi balali-mood medical toxicology research center, imam reza hospital, faculty of medicine, mashhad university of medical sciences, mashhad, iran ali asgharzadeh faculty of medicine, mashhad university of medical sciences, mashhad, iran mohammad hadi sadeghian cancer molecular pathology research center, ghaem hospital, faculty of medicine, mashhad university of medical sciences, mashhad, iran

objective(s):sulfur mustard (sm) was used by the iraqi army against the iranian troops in the iran-iraq war from 1983–1988. this chemical gas affects different organs including the skin, lungs and the hematopoietic system. any exposure to sm increases the risk of chromosomal breaking, hyperdiploidy and hypodiploidy. studies have shown that the risk for acute myeloblastic and lymphoblastic leuke...

Objective(s):Sulfur mustard (SM) was used by the Iraqi army against the Iranian troops in the Iran-Iraq war from 1983–1988. This chemical gas affects different organs including the skin, lungs and the hematopoietic system. Any exposure to SM increases the risk of chromosomal breaking, hyperdiploidy and hypodiploidy. Studies have shown that the risk for acute myeloblastic and lymphoblastic leuke...

2015
Hossein Ayatollahi Mohammad Rafiee Mohammad-Reza Keramati Mahdi Balali-Mood Ali Asgharzadeh Mohammad Hadi Sadeghian Maryam Sheikhi Nafiseh Amini Azam Moradi Zarmehri

OBJECTIVES Sulfur mustard (SM) was used by the Iraqi army against the Iranian troops in the Iran-Iraq war from 1983-1988. This chemical gas affects different organs including the skin, lungs and the hematopoietic system. Any exposure to SM increases the risk of chromosomal breaking, hyperdiploidy and hypodiploidy. Studies have shown that the risk for acute myeloblastic and lymphoblastic leukemi...

Background & Objective: FLT3-ITD mutation detection has been an integral part of diagnostic work ups focused on acute myeloid leukemia. However, some studies have indicated that the mutation is unstable during the various stages of the disease. The purpose of this study was to evaluate the stability of this marker in paired diagnosis-relapse samples using Delta-PCR method. Materials & Methods:...

Journal: :international journal of hematology-oncology and stem cell research 0
marjan yaghmaie medical genetics department, faculty of medical sciences, tarbiat modares university, tehran, iran hossein mozdarani medical genetics department, faculty of medical sciences, tarbiat modares university, tehran, iran kamran alimoghaddam hematology, oncology and stem cell transplantation research center, shariati hospital, tehran university, tehran, iran ardeshir ghavamzadeh hematology, oncology and stem cell transplantation research center, shariati hospital, tehran university, tehran, iran seyed hamiollah ghaffari hematology, oncology and stem cell transplantation research center, shariati hospital, tehran university, tehran, iran

introduction: the secondary genetic changes other than the pml-rara fusion gene may contribute to the acute promyelocytic leukemogenesis. chromosomal alterations and mutation of flt3 tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia (aml). however, the prognostic significance of flt3 mutations in acute promyelocytic leukemia (apl) is not firmly established....

Ardeshir Ghavamzadeh, Hossein Mozdarani, Kamran Alimoghaddam, Marjan Hajhashemi, Marjan Yaghmaie, Mozaffar Aznab, Seyed H. Ghaffari,

Background: The secondary genetic changes other than the promyelocytic leukemia-retinoic acid receptor (PML-RARA) fusion gene may contribute to the acute promyelocytic leukemogenesis. Chromosomal alterations and mutation of FLT3 (FMS-like tyrosine kinase 3) tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia. However, the prognostic significance of FLT3 mutat...

ژورنال: پیاورد سلامت 2013
اژدری, عبدالطیف, عباسی, سکینه, محمدی, شاهین,

Background and Aim: FLT3 gene is a member of class III receptor Tyrosine Kinase, which is expressed in most patients with acute myeloid leukemia (AML). Mutations of FLT3 such as Internal Tandem Duplication (ITD) and point mutation of the D835 are the most common genetic defects in myeloid leukemia. These two mutations in patients with MLA and their effect on survival rate were studied for the f...

بخشایش, معصومه, ذاکر, فرهاد, محمدی, محمد حسین, کاظمی, احمد ,

    Background and Aim: Molecular basis of Acute Myeloid Leukemia (AML) involves mutations in regulatory genes of cellular proliferation and differentiation.Mutation in tyrosine kinase receptor gene of FLT3 occurs in high frequency in AML, resulting in proliferation and abnormal survival of leukemia cells. Mutations in Internal Tandem Duplication (ITD) and D835 of FLT3 gene are associated with ...

Journal: :iranian biomedical journal 0
مرجان یغمایی marjan yaghmaie کامران علی مقدم kamran alimoghaddam حسین مزدرانی hossein mozdarani اردشیر قوام زاده ardeshir ghavamzadeh مرجان حاج قاسمی marjan hajhashemi مظفر ازنب mozaffar aznab سید حمداله غفاری

background: the secondary genetic changes other than the promyelocytic leukemia-retinoic acid receptor (pml-rara) fusion gene may contribute to the acute promyelocytic leukemogenesis. chromosomal alterations and mutation of flt3 (fms-like tyrosine kinase 3) tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia. however, the prognostic significance of flt3 mutat...

Background: Adult T cell leukemia lymphoma (ATLL) is a rare disease, significantly linked to the infection by the human T-cell lymphotropic virus 1(HTLV-1). ATLL is typically preceded by decades of clinical latency during which infected cells accumulate selectable traits leading to a malignant transformation. Amongst all the HTLV-1 infected carriers only about 3-5% will develop ATLL. Despite th...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید